Search Results - "Prince, H M"

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma by Quach, H, Ritchie, D, Stewart, A K, Neeson, P, Harrison, S, Smyth, M J, Prince, H M

“…Immunomodulatory drugs (IMiDs) are thalidomide analogues, which possess pleiotropic anti-myeloma properties including immune-modulation, anti-angiogenic,…”
Get full text

Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series by Nigrovic, Peter A., Mannion, Melissa, Prince, Femke H. M., Zeft, Andrew, Rabinovich, C. Egla, van Rossum, Marion A. J., Cortis, Elisabetta, Pardeo, Manuela, Miettunen, Paivi M., Janow, Ginger, Birmingham, James, Eggebeen, Aaron, Janssen, Erin, Shulman, Andrew I., Son, Mary Beth, Hong, Sandy, Jones, Karla, Ilowite, Norman T., Cron, Randy Q., Higgins, Gloria C.

“…Objective To examine the safety and efficacy of the interleukin‐1 (IL‐1) receptor antagonist anakinra as first‐line therapy for systemic juvenile idiopathic…”
Get full text

Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now? by Scarisbrick, J.J., Kim, Y.H., Whittaker, S.J., Wood, G.S., Vermeer, M.H., Prince, H.M., Quaglino, P.

“…Summary Mycosis fungoides is the most prevalent form of primary cutaneous T‐cell lymphoma. Patients frequently present with early‐stage disease typically…”
Get full text

Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort by Lillegraven, Siri, Prince, Femke H M, Shadick, Nancy A, Bykerk, Vivian P, Lu, Bing, Frits, Michelle L, Iannaccone, Christine K, Kvien, Tore K, Haavardsholm, Espen A, Weinblatt, Michael E, Solomon, Daniel H

“…One goal of remission in rheumatoid arthritis (RA) is to halt joint damage. The authors assessed the progression of radiographic joint damage among RA patients…”
Get more information

A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma by Cheah, C Y, Herbert, K E, O'Rourke, K, Kennedy, G A, George, A, Fedele, P L, Gilbertson, M, Tan, S Y, Ritchie, D S, Opat, S S, Prince, H M, Dickinson, M, Burbury, K, Wolf, M, Januszewicz, E H, Tam, C S, Westerman, D A, Carney, D A, Harrison, S J, Seymour, J F

“…Background: Central nervous system (CNS) relapse in diffuse large B-cell lymphoma (DLBCL) is a devastating complication; the optimal prophylactic strategy…”
Get full text

The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis by Holzinger, Dirk, Frosch, Michael, Kastrup, Astrid, Prince, Femke H M, Otten, Marieke H, Van Suijlekom-Smit, Lisette W A, ten Cate, Rebecca, Hoppenreijs, Esther P A H, Hansmann, Sandra, Moncrieffe, Halima, Ursu, Simona, Wedderburn, Lucy R, Roth, Johannes, Foell, Dirk, Wittkowski, Helmut

“…Analysis of myeloid-related protein 8 and 14 complex (MRP8/14) serum concentrations is a potential new tool to support the diagnosis of systemic-onset juvenile…”
Get more information

Prevalence and predictors for sustained remission in rheumatoid arthritis by Sung, Yoon-Kyoung, Yoshida, Kazuki, Prince, Femke H M, Frits, Michelle L, Cho, Soo-Kyung, Choe, Jung-Yoon, Lee, Hye-Soon, Lee, Jisoo, Lee, Shin-Seok, Yoo, Dae-Hyun, Helfgott, Simon M, Shadick, Nancy A, Weinblatt, Michael E, Solomon, Daniel H, Bae, Sang-Cheol

“…Remission is a key goal in managing rheumatoid arthritis (RA), with sustained remission as the preferred sequelae of short-term remission. However little is…”
Get full text

Limited role for surveillance PET–CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy by Cheah, C Y, Hofman, M S, Dickinson, M, Wirth, A, Westerman, D, Harrison, S J, Burbury, K, Wolf, M, Januszewicz, H, Herbert, K, Prince, H M, Carney, D A, Ritchie, D S, Hicks, R J, Seymour, J F

“…Background: The usefulness of positron emission tomography with computed tomography (PET–CT) in the surveillance of patients with diffuse large B-cell lymphoma…”
Get full text

Sustained rheumatoid arthritis remission is uncommon in clinical practice by Prince, Femke H M, Bykerk, Vivian P, Shadick, Nancy A, Lu, Bing, Cui, Jing, Frits, Michelle, Iannaccone, Christine K, Weinblatt, Michael E, Solomon, Daniel H

“…Remission is an important goal of therapy in rheumatoid arthritis (RA), but data on duration of remission are lacking. Our objective was to describe the…”
Get full text

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy by Carney, D A, Westerman, D A, Tam, C S, Milner, A, Prince, H M, Kenealy, M, Wolf, M, Januszewicz, E H, Ritchie, D, Came, N, Seymour, J F

“…Fludarabine combination chemotherapy achieves high response rates in chronic lymphocytic leukemia (CLL) and indolent lymphoma. The aim of this study was to…”
Get full text

Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis by Sung, Yoon-Kyoung, Yoshida, Kazuki, Prince, Femke H M, Frits, Michelle L, Cho, Soo-Kyung, Choe, Jung-Yoon, Lee, Hye-Soon, Lee, Jisoo, Lee, Shin-Seok, Yoo, Dae-Hyun, Helfgott, Simon M, Shadick, Nancy A, Weinblatt, Michael E, Solomon, Daniel H, Bae, Sang-Cheol

“…[This corrects the article DOI: 10.1371/journal.pone.0214981.]…”
Get full text

Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen by Peinert, S, Prince, H M, Guru, P M, Kershaw, M H, Smyth, M J, Trapani, J A, Gambell, P, Harrison, S, Scott, A M, Smyth, F E, Darcy, P K, Tainton, K, Neeson, P, Ritchie, D S, Hönemann, D

“…We have evaluated the carbohydrate antigen Lewis Y (Le Y ) as a potential target for T-cell immunotherapy of hematological neoplasias. Analysis of 81 primary…”
Get full text

The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study by FEYLER, S, PRINCE, H. M, COOK, G, PEARCE, R, TOWLSON, K, NIVISON-SMITH, I, SCHEY, S, GIBSON, J, PATTON, N, BRADSTOCK, K, MARKS, D. I

“…Peripheral T-cell lymphomas (PTCL) are a rare and heterogeneous subset of lymphomas with a poorer prognosis compared with B-cell lymphomas. We conducted a…”
Get full text

The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy by Gill, S., Carney, D., Ritchie, D., Wolf, M., Westerman, D., Prince, H.M., Januszewicz, H., Seymour, J.F.

“…Fludarabine-based chemoimmunotherapy has well-recognised efficacy and short-term toxicity in the treatment of lymphoid malignancies. However, the presence and…”
Get full text

Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial by Herbert, K E, Demosthenous, L, Wiesner, G, Link, E, Westerman, D A, Came, N, Ritchie, D S, Harrison, S, Seymour, J F, Prince, H M

“…The safety, kinetics and efficacy of plerixafor+pegfilgrastim for hematopoietic stem and progenitor cell (HSPC) mobilization are poorly understood. We treated…”
Get full text

Treatment of patients with advanced mycosis fungoides and Sézary syndrome with alemtuzumab by Kennedy, G. A., Seymour, J. F., Wolf, M., Januszewicz, H., Davison, J., McCormack, C., Ryan, G., Prince, H. M.

“…:  Objectives: Alemtuzumab (anti‐CD52, Campath‐1H) has recently been shown to be effective in the treatment of a range of hematological malignancies, including…”
Get full text

Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies by Tam, C.S., Galanos, J., Seymour, J.F., Pitman, A.G., Stark, R.J., Prince, H.M.

“…Reversible posterior leukoencephalopathy syndrome (RPLS) is an uncommon but distinctive clinicoradiological entity comprising of headache, seizures, visual…”
Get full text

Pegfilgrastim compared with filgrastim for cytokine-alone mobilization of autologous haematopoietic stem and progenitor cells by Herbert, K E, Gambell, P, Link, E K, Mouminoglu, A, Wall, D M, Harrison, S J, Ritchie, D S, Seymour, J F, Prince, H M

“…Haematopoietic stem and progenitor cells (HSPC) mobilization, using cytokine-alone, is a well-tolerated regimen with predictable mobilization kinetics…”
Get full text

Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients by Chan, A C, Neeson, P, Leeansyah, E, Tainton, K, Quach, H, Prince, H M, Godfrey, D I, Ritchie, D, Berzins, S P

“…Myelodysplastic syndrome (MDS) comprises a group of clonal bone marrow disorders characterized by ineffective hematopoiesis and increased predisposition to…”
Get full text

Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients by Goh, M.S.Y., McCormack, C., Dinh, H.V., Welsh, B., Foley, P., Prince, H.M.

“…Summary Background  Rituximab is a monoclonal antibody directed against the CD20 antigen expressed on B lymphocytes. There are reports of its efficacy in the…”
Get full text